Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Pet Pain-Away** is an unapproved homeopathic veterinary product marketed as a paste or gel for temporary relief of moderate to severe chronic pain in dogs and cats, particularly associated with arthritis, hip dysplasia, and inflamed joints. It contains **Asian cobra venom (Naja naja venom) 4X (70 mcg/mL)** as the active homeopathic ingredient, along with inactive ingredients like water, sorbitol, and carboxymethylcellulose sodium, flavored with chicken. According to traditional homeopathic practice and the Homeopathic Pharmacopeia of the United States, it provides analgesic effects via neuroactive peptides, though the FDA has not evaluated it for safety or efficacy. It is administered orally and is positioned as an all-natural alternative, distinct from the supplement Dog Pain Away which uses green-lipped mussel and herbs.[4][5][10][13][15]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pet Pain-Away.